PREVENTIVE EFFECTIVENESS OF PROPAFENONE IN PATIENTS WITH RECURRENT ATRIAL FIBRILLATION

PREVENTIVE EFFECTIVENESS OF PROPAFENONE IN PATIENTS WITH RECURRENT ATRIAL FIBRILLATION

.

Bibliographic Details
Main Authors:	R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2009-12-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1404

Similar Items

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY
by: R. D. Kurbanov, et al.
Published: (2015-12-01)

POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY
by: R. D. Kurbanov, et al.
Published: (2015-12-01)

Comparative Effectiveness of Aksaritmin and Propafenone in the Prevention of Atrial Fibrillation
by: Husniddin Sh. Kuchkarov, et al.
Published: (2023-06-01)

Propafenone mono- and combined therapy effectiveness in prevention of recurrent atrial fibrillation paroxysms
by: Yu. A. Bunin, et al.
Published: (2007-06-01)

Propafenone in complex anti-recurrent therapy of persistent atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2007-08-01)

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
by: N. N. Isakova, et al.
Published: (2006-06-01)

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
by: I. G. Fomina, et al.
Published: (2006-06-01)

Propafenone effectiveness for atrial fibrillation paroxysm treatment in a patient with thyrotoxic myocardial dystrophy
by: L. I. Levina, et al.
Published: (2005-08-01)

Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
by: V. I. Podzolkov, et al.
Published: (2018-08-01)

PREDICTION OF THROMBOEMBOLISM IN PATIENTS WITH LONG-LASTING ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2014-03-01)

Reduced progression of atrial fibrillation in hypertensive patients with long-term treatment of propafenone
by: A. I Tarzimanova, et al.
Published: (2016-06-01)

Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
by: Yu. A. Bunin, et al.
Published: (2005-12-01)

PREVENTIVE ANTIARRYTHMIC PHARMACOTHERAPY OF FREQUENT ATRIAL FIBRILLATION PAROXYSMS AND SOME SUPRAVENTRICULAR TACHYCARDIA VARIANTS WITH PROPAFENONE AGAINST PLACEBO
by: Yu. A. Bunin, et al.
Published: (2010-10-01)

Propafenone efficacy and safety in restoring and maintaining sinus rhythm in patients with recurrent atrial fibrillation: results of the open, prospective placebo-controlled trial
by: I. G. Fomina, et al.
Published: (2005-04-01)

Propafenone and lisinopril therapy effectiveness for sinus rhythm maintenance in patients with persistent atrial fibrillation and arterial hypertension (PROMETEY-III)
by: R. G. Oganov, et al.
Published: (1970-01-01)

Comparison of efficacy of pharmacological cardioversion with antazoline and propafenone versus electrical cardioversion in atrial fibrillation during cryoablation
by: Konrad Klocek, et al.
Published: (2024-03-01)

ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO
by: R. D. Kurbanov, et al.
Published: (2020-12-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation
by: I. G. Fomina, et al.
Published: (2005-08-01)

PROPAFENONE AND AMIODARONE EFFECTIVENESS IN CARDIAC PATIENTS WITH VENTRICULAR EXTRASYSTOLIA
by: N. Yu. Shmanova, et al.
Published: (2009-10-01)

Recurrent ischemic stroke in patients with atrial fibrillation: frequency, heterogeneity, prevention
by: L. A. Geraskina, et al.
Published: (2020-12-01)

Interrelation between the rs2200733 polymorphism of the ATFB5 gene and atrial fibrillation in Uzbek patients
by: Guzal Abdullaeva, et al.
Published: (2021-07-01)

New perspectives of recurrent atrial fibrillation prevention in coronary heart disease patients
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation (part II)
by: I. G. Fomina, et al.
Published: (2005-10-01)

EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HEART FAILURE WITH INTACT LEFT VENTRICULAR SYSTOLIC FUNCTION
by: O. N. Miller, et al.
Published: (2010-08-01)

Amiodarone Versus Propafenone to Treat Atrial Fibrillation after Coronary Artery Bypass Grafting: A Randomized Double Blind Controlled Trial
by: Mohammad Hassan Nemati, et al.
Published: (2016-06-01)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
by: van Walraven, C, et al.
Published: (2009)

Results of propafenone use in early postoperative period after pulmonary veins catheter radiofrequency isolation for prevention of early atrial tachyarrhythmias
by: A. V Tarasov, et al.
Published: (2015-06-01)

Propafenone and propranolol dual toxicity
by: Moonis Farooq, et al.
Published: (2020-10-01)

Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study
by: Hesham S. Taha, et al.
Published: (2022-05-01)

Recurrence of atrial fibrillation and late cardiovascular events in patients with persistent atrial fibrillation after restoration of sinus rhythm
by: U.P. Chernyaha-Royko, et al.
Published: (2020-06-01)

“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism
by: Linling Li, et al.
Published: (2019-03-01)

How to prevent recurrence of atrial fibrillation after catheter ablation
by: Naoya Kataoka, et al.
Published: (2024-02-01)

Antiarrhythmic effects of newly developed propafenone derivatives
by: Ivković Branka, et al.
Published: (2022-01-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
by: IRAJ NAZERY, et al.
Published: (1986-05-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
by: IRAJ NAZERY , et al.
Published: (1986-12-01)

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence
by: Youzheng Dong, et al.
Published: (2022-09-01)

Stroke prevention in patients with atrial fibrillation and comorbidities
by: O D Ostroumova, et al.
Published: (2018-06-01)